湿罐疗法治疗强直性脊柱炎
Wet Cupping Therapy in Ankylosing Spondylitis: a Multicenter Quasi- Randomised Controlled Trial
This study evaluates the efficacy of wet cupping therapy in patients with ankylosing spondylitis.Wet cupping therapy will be applied to half of the patients plus routine pharmaceutical treatment while the other half will receive only pharmaceutics
研究概览
详细说明
In addition to the medical treatment, WCT will be applied once every 28 days , 3 times (Day 0, 28, 56) to the intervention group whereas the control group will not receive any intervention. The BASFI, BASDAI, CRP, FFD, VAS and Modified Schober (MSI) tests will be applied to both groups at 0 and 3 months.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Karabük、土耳其(türkiye)
- Karabuk University
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Age between 18-65 years
- Confirmed diagnosis of ankylosing spondylitis (AS) according to the modified New York criteria or the ASAS classification criteria for axial spondyloarthritis
- Active disease at enrolment, confirmed by a PM&R specialist
- Written informed consent and compliance with the study protocol
Exclusion Criteria:
- Having received WCT within the previous 3 months
- Contraindications to WCT (hemoglobin <9.5 g/dL, known bleeding or coagulation disorders, anticoagulant use or antiplatelet therapy other than aspirin <100 mg, INR >1.5, etc.)
- Pregnancy or breastfeeding
- Severe uncontrolled comorbidities (e.g., advanced cardiovascular disease, uncontrolled diabetes, active malignancy, severe psychiatric illness)
- Any change in AS medication during the study period
- Failure to complete either baseline or follow-up visits
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Wet cupping arm
This arm is the interventiom group and will receive three consecutive sessions of wet cupping therapy once a month. |
wet cupping therapy will be applied to participants in this arm for three sessions once a month |
|
无干预:Control arm
This arm is the control group and will not receive any intervention other than the routine medications |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
BASDAI
大体时间:At 0 and 9th weeks
|
Change in the scores of The Bath Ankylosing Spondylitis Disease Activity Index |
At 0 and 9th weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Schober
大体时间:At 0 and 9th weeks
|
Change in the scores of Modified Schober Test |
At 0 and 9th weeks
|
|
BASFI
大体时间:At 0 and 9th weeks
|
Change in the scores of The Bath Ankylosing Spondylitis Functional Index |
At 0 and 9th weeks
|
|
VAS
大体时间:At 0 and 9th weeks
|
Change in the scores of Visual Analogue Scale |
At 0 and 9th weeks
|
|
C Reactive Protein (CRP)
大体时间:At 0 and 9th weeks
|
Changes in the values of CRP |
At 0 and 9th weeks
|
|
fingertip-to-floor distance (FFD),
大体时间:0 th and 9 th weeks
|
Changes in the values of fingertip-to-floor distance (FFD), |
0 th and 9 th weeks
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.